Bruker Corp has a consensus price target of $69.18, established from looking at the 23 latest analyst ratings. The last 3 analyst ratings were released from Goldman Sachs, UBS, and UBS on April 10, 2024, March 1, 2024, and February 15, 2024. With an average price target of $90 between Goldman Sachs, UBS, and UBS, there's an implied 14.56% upside for Bruker Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/10/2024 | BRKR | Buy Now | Bruker | $78.56 | -5.8% | Goldman Sachs | Matthew Sykes | $66 → $74 | Maintains | Sell | Get Alert |
03/01/2024 | BRKR | Buy Now | Bruker | $78.56 | 29.84% | UBS | John Sourbeer | $94 → $102 | Maintains | Buy | Get Alert |
02/15/2024 | BRKR | Buy Now | Bruker | $78.56 | 19.65% | UBS | John Sourbeer | $86 → $94 | Maintains | Buy | Get Alert |
02/14/2024 | BRKR | Buy Now | Bruker | $78.56 | 20.93% | Citigroup | Patrick Donnelly | $80 → $95 | Maintains | Buy | Get Alert |
02/14/2024 | BRKR | Buy Now | Bruker | $78.56 | 3.11% | Stifel | Daniel Arias | $63 → $81 | Maintains | Hold | Get Alert |
02/14/2024 | BRKR | Buy Now | Bruker | $78.56 | 14.56% | JP Morgan | Tycho Peterson | $60 → $90 | Upgrade | Neutral → Overweight | Get Alert |
12/19/2023 | BRKR | Buy Now | Bruker | $78.56 | -8.35% | Wells Fargo | Timothy Daley | → $72 | Initiates | → Equal-Weight | Get Alert |
12/13/2023 | BRKR | Buy Now | Bruker | $78.56 | — | Wolfe Research | Doug Schenkel | — | Initiates | → Outperform | Get Alert |
10/17/2023 | BRKR | Buy Now | Bruker | $78.56 | -17.26% | JP Morgan | Tycho Peterson | $70 → $65 | Maintains | Neutral | Get Alert |
05/05/2023 | BRKR | Buy Now | Bruker | $78.56 | 20.93% | Citigroup | Patrick Donnelly | $90 → $95 | Maintains | Buy | Get Alert |
04/19/2023 | BRKR | Buy Now | Bruker | $78.56 | -10.9% | Goldman Sachs | Matthew Sykes | $63 → $70 | Maintains | Sell | Get Alert |
04/18/2023 | BRKR | Buy Now | Bruker | $78.56 | -10.9% | Goldman Sachs | — | $63 → $70 | Maintains | Sell | Get Alert |
02/10/2023 | BRKR | Buy Now | Bruker | $78.56 | 14.56% | Citigroup | Patrick Donnelly | $80 → $90 | Maintains | Buy | Get Alert |
10/21/2022 | BRKR | Buy Now | Bruker | $78.56 | -10.9% | UBS | John Sourbeer | → $70 | Initiates | → Buy | Get Alert |
08/22/2022 | BRKR | Buy Now | Bruker | $78.56 | 1.83% | Citigroup | Patrick Donnelly | $70 → $80 | Upgrade | Neutral → Buy | Get Alert |
05/05/2022 | BRKR | Buy Now | Bruker | $78.56 | 10.74% | SVB Leerink | Puneet Souda | $85 → $87 | Maintains | Outperform | Get Alert |
04/13/2022 | BRKR | Buy Now | Bruker | $78.56 | -23.63% | Goldman Sachs | — | $73 → $60 | Maintains | Sell | Get Alert |
02/14/2022 | BRKR | Buy Now | Bruker | $78.56 | 8.2% | SVB Leerink | Puneet Souda | $84 → $85 | Maintains | Outperform | Get Alert |
11/02/2021 | BRKR | Buy Now | Bruker | $78.56 | 14.56% | Wells Fargo | Dan Leonard | — | Maintains | Equal-Weight | Get Alert |
The latest price target for Bruker (NASDAQ: BRKR) was reported by Goldman Sachs on April 10, 2024. The analyst firm set a price target for $74.00 expecting BRKR to fall to within 12 months (a possible -5.80% downside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Bruker (NASDAQ: BRKR) was provided by Goldman Sachs, and Bruker maintained their sell rating.
The last upgrade for Bruker Corp happened on February 14, 2024 when JP Morgan raised their price target to $90. JP Morgan previously had a neutral for Bruker Corp.
There is no last downgrade for Bruker.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
While ratings are subjective and will change, the latest Bruker (BRKR) rating was a maintained with a price target of $66.00 to $74.00. The current price Bruker (BRKR) is trading at is $78.56, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.